Digital Technology Allows Kenyans To Access Medical Awareness On Chronic Diseases

Written by

There is currently an unmet need for efficient and widely accessible care for hypertension and diabetes in Kenya, where prevalence among adults is high, with low levels of awareness, treatment, and control. Notably, over 50% of patients with diabetes or hypertension are not aware of their diagnosis, and many have scarce knowledge of non-communicable diseases (NCDs) or are not compliant with treatment.

In a quest to let more citizens in on such crucial information, Boehringer Ingelheim, a pharmaceutical company and PharmAccess have launched ‘Tiba Yako’ program that will allow Kenyans to access awareness; for both medical and personal care in hypertension and diabetes through their mobile phone.

The Tiba Yako program screens and directly supports positively screened patients with awareness, access, and adherence to diabetes and hypertension care. The mobile phone is the linking pin in this integrated approach.

PharmAccess and partners developed a digital payment platform for healthcare called M-TIBA. M-TIBA provides access to healthcare by connecting people to clinics and healthcare funders, directly through a wallet on their mobile phone, and exchanging money and data between them.

Digital Technology

Within the Tiba Yako program, the platform will now also provide access support for hypertension and diabetes care in the mobile wallets of low-income patients, which they can use to co-pay for care at selected clinics in Nairobi, Kiambu and Vihiga Country. Moreover, the program allows patients to monitor their blood pressure and blood glucose levels at their convenience at home, digitally sending the results to their doctor for review. Combined with digital awareness and self-management support through an innovative app called Afya Pap, this integrated approach aims to increase symptom recognition and treatment adherence.

See also  Safaricom partners with the health sector to create a mobile health wallet

The Tiba Yako program is in line with the ‘In Reach Africa’ initiative of Boehringer Ingelheim, which aims at facilitating quality and access of human and animal healthcare across the African continent. “Our fundamental priority in the region is to develop solutions that enable screening and education. With Tiba Yako, we have a clear strategy in place to improve access to healthcare for those in need.’’ Ayman Eissa, Head of Human Pharmaceuticals across the Sub Saharan Africa, Boehringer Ingelheim

Isaiah Okoth, Country Director- PharmAccess: ‘‘Digital technology enables directly supporting people to access care, and enables people to self-manage and control their disease from home. The Tiba Yako program supports hypertension and diabetes patients and enables them to take control of their own health’’.



What is your opinion on the topic?
Article Categories: